📅 2026 Update: Recent Changes in Controlled Substances Regulations

Since the original article was written, there have been significant updates regarding the prescribing of controlled substances, particularly in telehealth settings. These changes aim to improve access to essential medications while ensuring patient safety. The earlier article continues further down the page, providing more context about Darvon and Darvocet.

🩺 Telemedicine Flexibilities Extended

The U.S. Department of Health and Human Services (HHS) and the Drug Enforcement Administration (DEA) have extended telemedicine flexibilities for prescribing controlled substances through December 31, 2026. This means that DEA-registered practitioners can prescribe Schedule II-V medications via telehealth without needing a prior in-person visit, making it easier for patients to access necessary treatments.

💊 Permanent Buprenorphine Telemedicine Rules

On January 17, 2025, the DEA and HHS issued a final rule that made telemedicine flexibilities for prescribing buprenorphine permanent. This medication is vital for treating opioid use disorder, enhancing access to care for those in need and allowing practitioners to provide treatment remotely.

📋 Strengthening Mental Health Parity

New rules were released on September 9, 2024, to enhance parity between mental health, substance use disorder benefits, and traditional medical benefits. Effective from November 22, 2024, these rules ensure that health plans cannot impose stricter limitations on mental health and substance use disorder benefits compared to medical services.

⏳ No Deadlines for Buprenorphine Treatment

Unlike other telehealth services, there are no specific deadlines for initiating buprenorphine treatment via telemedicine. Patients can seek this treatment at any time, allowing for greater flexibility in receiving care.

📌 Key Points to Remember

  • 📅 Telemedicine flexibilities for controlled substances last until December 31, 2026.
  • 💊 Buprenorphine prescribing via telemedicine is now permanent.
  • 🧠 New rules strengthen mental health and substance use disorder benefit parity.
  • ⏳ No specific deadlines exist for starting buprenorphine treatment.
  • 🔍 Check individual provider policies for telehealth services and costs.

💡 Tips for Navigating Controlled Substances Regulations

Review your unique circumstances with an attorney to get tailored information about your situation.

🩺 Understand Telehealth Limitations

Not all telehealth platforms can prescribe controlled substances. Some providers, like Teladoc Health, do not prescribe medications like Adderall and Ambien due to federal and state regulations. Always verify if your chosen provider can meet your needs.

💵 Check Costs Beforehand

Costs for telehealth consultations can vary widely. Some platforms offer subscription models, while others charge per visit. It's essential to check with individual providers to understand their pricing structure before scheduling.

📅 Prepare for Consultations

Before a telehealth appointment for a controlled substance, be ready for a video consultation. The practitioner will review your medical history and current condition to determine if a prescription is appropriate.

🔄 Stay Informed About Changes

Regulations surrounding controlled substances can change frequently. Stay updated on any new rules or guidelines regarding telehealth prescriptions to ensure you have access to necessary medications.

🆓 Utilize Available Resources

If you need help or information regarding substance use disorders, consider reaching out to organizations like the Substance Abuse and Mental Health Services Administration (SAMHSA). Their national helpline can provide valuable support and resources.

🏆 Services for Controlled Substance Management Ranked by User Reviews (2026)

This section highlights various telehealth services relevant to managing controlled substances and mental health care. The order is based on Trustpilot data checked in October 2026. Star ratings can shift over time, and they reflect user experiences, with unhappy customers often leaving more feedback.

🥇 1. Direct Meds

Direct Meds has been rated 4.6. This service is known for its telehealth offerings, especially with medications like semaglutide and tirzepatide. However, customers have noted limited insurance acceptance and potential side effects from medications as drawbacks.

🥈 2. Hims & Hers Health

Hims & Hers Health has a Trustpilot score of 3.0. This platform provides a range of online healthcare services, including prescription medications related to mental health and personal care. Some users report customer service issues and concerns about product effectiveness.

🥉 3. LifeStance Health

LifeStance Health holds a score of 4.0. It is recognized for its mental health services, including therapy and psychiatry, offered via telehealth. Users have mentioned inconsistent service quality and challenges with appointment availability.

4️⃣ Talkiatry

Talkiatry has a lower rating of 2.4. This service specializes in online psychiatry and medication management. Reviewers have noted limited insurance coverage and varying quality among clinicians as areas of concern.

🆓 Free Government and Nonprofit Help

The U.S. Department of Labor provides resources related to mental health parity and addiction equity. Additionally, the Substance Abuse and Mental Health Services Administration (SAMHSA) offers a national helpline for individuals seeking treatment information and referrals, ensuring access to vital support.

🔎 Key Considerations for Choosing a Service

  • 🌐 Check for telehealth prescription capabilities.
  • 💰 Compare costs and potential insurance coverage.
  • 📅 Evaluate appointment availability and scheduling flexibility.
  • 🧠 Review service quality and user feedback.
  • 📞 Consider available support resources for substance use disorders.

❓ Frequently Asked Questions

🤔 What is the latest deadline for telehealth prescriptions?

The current telemedicine flexibilities for prescribing controlled substances are effective until December 31, 2026.

📅 Can I receive buprenorphine treatment anytime?

Yes, there are no specific deadlines for initiating buprenorphine treatment via telemedicine. Patients can seek this treatment whenever they need it.

💻 Do I need to see a doctor in person to get a prescription?

No, patients can obtain prescriptions for controlled substances through telehealth consultations with DEA-registered practitioners, as long as they have a video consultation.

🏥 Are there costs associated with telehealth prescriptions?

Yes, costs vary by provider for telehealth consultations regarding controlled substances. It's important to check with individual providers for their specific pricing.

📞 Where can I find help for substance use disorders?

The Substance Abuse and Mental Health Services Administration (SAMHSA) offers a national helpline at 1-800-662-HELP (4357) for individuals seeking information and treatment referrals.

📋 What should I prepare for my telehealth appointment?

Before your telehealth appointment, prepare your medical history and current condition details, as the practitioner will review these during the consultation to assess your needs.

⚖️ Recent Cases Related to Controlled Substances

Recent court rulings have addressed various aspects of drug regulation and prescribing practices related to controlled substances. These rulings highlight the ongoing evaluation of drug laws and patient access to necessary medications.

For more recent rulings, feel free to browse more rulings on the news page.

End of October 2026 Update






What is Darvon/Darvocet?



 



 

Darvon and Darvocet


Darvon and Darvocet are banned medications that used to prescribed as painkillers since the 1950s. Darvon is the brand name for the compound propoxyphene and Darvocet is propoxyphene mixed with acetaminophen with both being linked to abnormal heart rhythm.



 



 



The FDA forced the manufacturer – Xanodyne to conduct clinical tests in 2009 where they found a greater than normal risk of developing complications, which led to Darvocet coming off the market in 2010. In 2009 nearly 10 million Americans were taking medication with some form of propoxyphene. The UK and European Union had banned the medication several years earlier.



 



 



What are the risks of Darvon and Darvocet?



 



 



Although it took several decades to establish a link, it is now conclusively proven that these drugs have caused serious cardiac side effects that far outweigh the benefit of its use as a painkiller. Propoxyphene remains in the body long after the dosage and remains toxic to the heart where it interrupts heart rhythm by slowing down contractions and interrupting electrical impulses to the heart. There have been indications and suspicions of this link for a number of decades which has lead the public advocacy group Public Citizen’s to decry that the FDA has been negligent in controlling and studying the potential risks of propoxyphene medication.



 



 



In 2009, prior to the ban, the FDA allowed Darvon/Darvocet to continue to be marketed with warning labels about potentially fatal overdoses. Later studies showed that propoxyphene medications had a higher risk of drug-related deaths than similar drugs with nearly 16 deaths per 100,000 prescriptions. In the unlikely event that you are still taking Darvon/Darvocet after the recall, you must contact your doctor immediately. Doses should not stop suddenly but should be drawn down and replaced by another painkiller, at your doctor’s discretion.



 



 



What should I do if I or a loved one has been harmed by taking Darvon and Darvocet?



 



 



The FDA and the manufacturer Xanodyne ignored warning signs about the drugs for a number of years and motions to pull the drug from the market were filed as early as 1978. This lack of acknowledgement over the associated risks can be used to hold the drug company liable for damages to cover medical bills, lost wages as well as pain and suffering associated with harm caused by this drug. Lawsuits associated with harm caused by this drug are subject to the statue of limitations which means that if the patient or family of the patient intends to sue, they must do it in a timely manner before the chance expires.